Associated Papers
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression.
Sigarteu Chindris AM et al.
Frontiers in Endocrinology, 2024
39717106 (PubMed )
Supplement: Table8.xlsx › S_Tab._8_TCGA
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.
Veschi V et al.
Nature Communications, 2023
36906579 (PubMed )
Supplement: 41467_2023_36922_MOESM6_ESM.zip › 356656_2_data_0_rq37ls.xlsx › Figure_2f
Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis.
Yi Q et al.
Frontiers in Bioengineering and Biotechnology, 2022
35910024 (PubMed )
Supplement: Table2.XLSX › table
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Hescheler DA et al.
Frontiers in Endocrinology, 2021
34630336 (PubMed )
Supplement: Table_1.xlsx › Tab3
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
30053901 (PubMed )
Supplement: 13073_2018_564_MOESM2_ESM.xlsx › 19
Select a paper to view details